A Mini-Review of Traditional Chinese Medicines on Liver Diseases

[1]  Yang Li,et al.  Preliminary Structural Characterization of Selenium Nanoparticle Composites Modified by Astragalus Polysaccharide and the Cytotoxicity Mechanism on Liver Cancer Cells , 2023, Molecules.

[2]  Reham S. Ibrahim,et al.  Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study , 2022, Scientific Reports.

[3]  M. Atia,et al.  Nanocurcumin and curcumin prevent N, N'-methylenebisacrylamide-induced liver damage and promotion of hepatic cancer cell growth , 2022, Scientific reports.

[4]  E. Feist,et al.  Curcumin: Useful add-on for Rheumatic Diseases? , 2022, Journal of clinical medicine.

[5]  H. Shum,et al.  Celastrol-Lac-BSA nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Zelin Lai,et al.  Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology , 2021, BMC Complementary Medicine and Therapies.

[7]  Xia Liu,et al.  Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives , 2021, Chinese Medicine.

[8]  Mian-hua Wu,et al.  Celastrol induces caspase-dependent apoptosis of hepatocellular carcinoma cells by suppression of mammalian target of rapamycin. , 2021, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[9]  N. Chalasani,et al.  ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. , 2021, The American journal of gastroenterology.

[10]  Chuanshan Xu,et al.  “Celastrol” for Atopic Dermatitis , 2021 .

[11]  Wenchao Tang,et al.  Protective mechanism of Astragalus Polysaccharides against Cantharidin‐induced liver injury determined in vivo by liquid chromatography/mass spectrometry metabolomics , 2021, Basic & clinical pharmacology & toxicology.

[12]  Piao Zheng,et al.  Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues , 2021, Oncology letters.

[13]  Hailong Si,et al.  Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis , 2021, Cancer management and research.

[14]  Chuanshan Xu,et al.  Traditional Chinese medicine, “Celastrol” and its nanotechnology for cancers: a narrative review , 2021, Longhua Chinese Medicine.

[15]  Qiang Xu,et al.  Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice , 2020, Acta pharmaceutica Sinica. B.

[16]  Yuanzhang Hu,et al.  Efficacy and safety of Buzhong Yiqi decoction combined with surgery for rectal prolapse , 2020, Medicine.

[17]  F. Gonzalez,et al.  Celastrol ameliorates acute liver injury through modulation of PPARα. , 2020, Biochemical pharmacology.

[18]  Yong Guo,et al.  Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect. , 2020, Journal of ethnopharmacology.

[19]  Zhimin Chen,et al.  Different Processed Products of Curcumae Radix Regulate Pain-Related Substances in a Rat Model of Qi Stagnation and Blood Stasis , 2020, Frontiers in Pharmacology.

[20]  Feng Zhang,et al.  Liver regeneration in traditional Chinese medicine: advances and challenges , 2020, Regenerative medicine research.

[21]  A. Shaheen,et al.  Astragalus membranaceus nanoparticles markedly improve immune and anti-oxidative responses and protection against Aeromonas veronii in Nile tilapia Oreochromis niloticus. , 2019, Fish & shellfish immunology.

[22]  F. Gonzalez,et al.  Herbal drug discovery for the treatment of nonalcoholic fatty liver disease , 2019, Acta pharmaceutica Sinica. B.

[23]  W. Lv,et al.  Research Progress in Astragalus Membranaceus and Its Active Components on Immune Responses in Liver Fibrosis , 2019, Chinese Journal of Integrative Medicine.

[24]  R. Glávits,et al.  Toxicological Evaluation of a Mixture of Astragalus membranaceus and Panax notoginseng Root Extracts (InnoSlim®) , 2019, Journal of toxicology.

[25]  Zheng,et al.  The Effects of Astragalus membranaceus Active Extracts on Autophagy-Related Diseases , 2019, International journal of molecular sciences.

[26]  T. Brzozowski,et al.  Curcumin: A Potent Protectant against Esophageal and Gastric Disorders , 2019, International journal of molecular sciences.

[27]  F. Gonzalez,et al.  Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling* , 2019, Molecular & Cellular Proteomics.

[28]  Lai Wei,et al.  Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China) , 2018, Journal of digestive diseases.

[29]  M. Farzaei,et al.  Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective , 2018, Nutrients.

[30]  J. Dvořáčková,et al.  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun; 162(2) , 2018 .

[31]  Ji Wang,et al.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. , 2018, Experimental and therapeutic medicine.

[32]  R. Ahmad,et al.  Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs , 2017, Journal of traditional and complementary medicine.

[33]  I. Ullah,et al.  Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions , 2017, Phytotherapy research : PTR.

[34]  J. Fonseca,et al.  Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases , 2017, Front. Med..

[35]  Ning Wang,et al.  Liver Cancer Treatment by Chinese Medicines and their Active Compounds , 2016 .

[36]  Jing Zhang,et al.  Chinese herbal medicine for subfertile women with polycystic ovarian syndrome. , 2016, The Cochrane database of systematic reviews.

[37]  S. Asgary,et al.  Treatment of Non‐alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo‐controlled Trial , 2016, Phytotherapy research : PTR.

[38]  K. Moudgil,et al.  Control of autoimmune inflammation by celastrol, a natural triterpenoid. , 2016, Pathogens and disease.

[39]  M. Yuen,et al.  Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities , 2016, International journal of molecular sciences.

[40]  Yinglan Zhao,et al.  Nano Traditional Chinese Medicine: Current Progresses and Future Challenges. , 2015, Current drug targets.

[41]  Li-li Yin,et al.  Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction. , 2015, International journal of clinical and experimental pathology.

[42]  Yu-qi Gao,et al.  Astragalus on the anti-fatigue effect in hypoxic mice. , 2015, International journal of clinical and experimental medicine.

[43]  Lie-ming Xu,et al.  Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities , 2014, Journal of Integrative Medicine.

[44]  C. Day,et al.  Treatment of Non-Alcoholic Fatty Liver Disease , 2014, Digestive Diseases.

[45]  C. Song,et al.  Negative Effects of Curcumin on Liver Injury Induced by Alcohol , 2012, Phytotherapy research : PTR.

[46]  J. Luk,et al.  Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo , 2012, Cancer Prevention Research.

[47]  S. Rajasekaran.  Therapeutic potential of curcumin in gastrointestinal diseases. , 2011, World journal of gastrointestinal pathophysiology.

[48]  Jian-Mei Li,et al.  Curcumin inhibits hepatic protein‐tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose‐fed rats , 2010, Hepatology.

[49]  Yan-an Cheng,et al.  Protective effects of emodin and astragalus polysaccharides on chronic hepatic injury in rats. , 2008, Chinese medical journal.

[50]  Cheng Xiao,et al.  Theory of traditional Chinese medicine and therapeutic method of diseases. , 2004, World journal of gastroenterology.

[51]  N. Chainani-Wu.  Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.

[52]  C. Zhen,et al.  [The effect of Astragalus membranaceus (Fisch) bge. on lipid peroxidation and NO level of myocardium from rats with diabetic nephropathy]. , 2001, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology.

[53]  Chuanshan Xu,et al.  Traditional Chinese herb, Astragalus: possible for treatment and prevention of COVID-19? , 2020 .

[54]  J. Qin,et al.  Astragalus polysaccharides attenuates TNF-α-induced insulin resistance via suppression of miR-721 and activation of PPAR-γ and PI3K/AKT in 3T3-L1 adipocytes. , 2017, American journal of translational research.

[55]  B. Liu,et al.  Curcumin inhibits MHCC97H liver cancer cells by activating ROS/TLR-4/caspase signaling pathway. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[56]  Bin Wang,et al.  Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo , 2012, Indian journal of pharmacology.

[57]  Mohammed Al Mutani,et al.  Complications of Hot Turmeric Use in Acute Trauma. , 2010, Oman medical journal.

[58]  M. Dieterich,et al.  Hyperhidrosis--causes and treatment of enhanced sweating. , 2009, Deutsches Arzteblatt international.

[59]  Guangyong Chen,et al.  Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats , 2002, Cancer Chemotherapy and Pharmacology.